FDA 483 - Happy Farm Botanicals - March 15, 2024

During an FDA inspection conducted from March 12-15, 2024, Happy Farm Botanicals, a contract manufacturer, received a Form 483 detailing two significant observations. The inspection highlighted deficiencies in the firm's quality management system concerning the manufacturing of drug products, including over-the-counter (OTC) items like Zinc Oxide 17% SPF 30 Broad Spectrum Mineral Facial Sunscreen.The primary issue observed was the failure to establish comprehensive written procedures for production and process controls. Specifically, the company had not performed adequate process validation, resulting in insufficient data to ensure that manufactured drug products consistently meet their identity, strength, purity, and quality specifications throughout their established shelf life. Additionally, the firm's equipment cleaning and maintenance procedures were found to be deficient. There was no evidence of cleaning validation, leading to insufficient data to confirm manufacturing equipment was thoroughly clean before use. Current cleaning protocols also lacked critical details, such as specific detergents, proper dilution instructions, and guidance for equipment disassembly and reassembly necessary for effective cleaning. Happy Farm Botanicals is expected to respond to these observations with comprehensive corrective and preventive actions to ensure compliance with federal regulations governing drug manufacturing, thereby upholding product quality and safety.